📣 VC round data is live. Check it out!

Nano X Imaging Valuation Multiples

Discover Nano X Imaging's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Airdoc, Fonet, Bioneer, Findex and more.

Nano X Imaging Overview

About Nano X Imaging

Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.


Founded

2018

HQ

United States

Employees

165

Financials (LTM)

Revenue: $21M
Net Income: ($63M)

EV

$82M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Nano X Imaging Financials

Nano X Imaging reported last 12-month revenue of $21M.

In the same LTM period, Nano X Imaging generated ($7M) in gross profit and had net loss of ($63M).

Revenue (LTM)


Nano X Imaging P&L

In the most recent fiscal year, Nano X Imaging reported revenue of $13M and EBITDA of ($49M).

Nano X Imaging is unprofitable as of last fiscal year, with gross margin of (98%), EBITDA margin of (376%), and net margin of (576%).

See analyst estimates for Nano X Imaging
LTMLast FY202320242025202620272028
Revenue$21M$13M$10M$11M$13M
Gross Profit($7M)($13M)($7M)($11M)($13M)
Gross Margin(35%)(98%)(67%)(94%)(98%)
EBITDA-($49M)($48M)($45M)($49M)
EBITDA Margin-(376%)(483%)(399%)(376%)
EBIT Margin(322%)(466%)(602%)(503%)(466%)
Net Profit($63M)($75M)($61M)($54M)($75M)
Net Margin(308%)(576%)(614%)(474%)(576%)

Financial data powered by Morningstar, Inc.

Nano X Imaging Stock Performance

Nano X Imaging has current market cap of $134M, and enterprise value of $82M.

Market Cap Evolution


Nano X Imaging's stock price is $1.92.

Nano X Imaging share price decreased by 62.8% in the last year.

Nano X Imaging has an EPS (earnings per share) of $-1.08.

See more trading valuation data for Nano X Imaging
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$82M$134M-1.5%0.0%-15.4%-62.8%$-1.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Nano X Imaging Valuation Multiples

Nano X Imaging trades at 4.0x EV/Revenue multiple, and (1.7x) EV/EBITDA.

See NTM and 2027E valuation multiples for Nano X Imaging

EV / Revenue (LTM)


Nano X Imaging Financial Valuation Multiples

As of June 3, 2026, Nano X Imaging has market cap of $134M and EV of $82M.

Nano X Imaging has a P/E ratio of (2.1x).

LTMLast FY202320242025202620272028
EV/Revenue4.0x6.3x8.3x7.3x6.3x
EV/EBITDA-(1.7x)(1.7x)(1.8x)(1.7x)
EV/EBIT(1.2x)(1.3x)(1.4x)(1.4x)(1.3x)
EV/Gross Profit(11.3x)(6.4x)(12.4x)(7.7x)(6.4x)
P/E(2.1x)(1.8x)(2.2x)(2.5x)(1.8x)
EV/FCF-(1.8x)(1.7x)(2.1x)(1.8x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Nano X Imaging Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Nano X Imaging Margins & Growth Rates

Nano X Imaging grew revenue by 136% but net profit decreased by 38% in the last fiscal year.

In the most recent fiscal year, Nano X Imaging reported gross margin of (98%), EBITDA margin of (376%), and net margin of (576%).

See estimated margins and future growth rates for Nano X Imaging

Nano X Imaging Margins

Last FY202420252026202720282029
Gross Margin(98%)(94%)(98%)1%
EBITDA Margin(376%)(399%)(376%)-
EBIT Margin(466%)(503%)(466%)(160%)
Net Margin(576%)(474%)(576%)(152%)
FCF Margin(346%)(349%)(346%)-

Nano X Imaging Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth136%14%15%136%
Gross Profit Growth(102%)61%21%(102%)
EBITDA Growth-(6%)9%-
EBIT Growth(19%)(5%)7%(19%)
Net Profit Growth(38%)(12%)40%(38%)
FCF Growth-(18%)14%-

Data powered by FactSet, Inc. and Morningstar, Inc.

Nano X Imaging Operational KPIs

Nano X Imaging's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.3M for the same period.

Access forward-looking KPIs for Nano X Imaging
LTMLast FY202320242025202620272028
Revenue per Employee-$0.1M---
Opex per Employee-$0.3M---
S&M Expenses to Revenue34%44%24%15%20%
G&A Expenses to Revenue106%188%263%214%188%
R&D Expenses to Revenue92%148%263%179%148%
Opex to Revenue-368%536%409%368%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Nano X Imaging Competitors

Nano X Imaging competitors include Airdoc, Fonet, Bioneer, Findex, Kanamic Network, Fonar, Hyperfine, Infinitt Healthcare, Exagen and Apiam Animal Health.

Most Nano X Imaging public comparables operate across Medical Imaging & Diagnostics, Healthcare Software, HealthTech, B2B SaaS, Vertical SaaS and Longevity.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Airdoc1.6x1.6x(41.9x)-
Fonet6.7x-13.6x-
Bioneer0.7x-9.8x-
Findex2.9x2.9x8.2x8.2x
Kanamic Network3.6x3.4x9.8x9.5x
Fonar1.0x-5.7x-
Hyperfine9.0x7.5x(3.5x)(3.6x)
Infinitt Healthcare(0.1x)-(0.4x)-

This data is available for Pro users. Sign up to see all Nano X Imaging competitors and their valuation data.

Start Free Trial

Nano X Imaging VC Funding History

Before going public, Nano X Imaging raised $114M in total equity funding, across 4 rounds.

Last private valuation of Nano X Imaging was $600M, after raising $59M in July 2020 from Cloud Network Technology, Industrial Alliance Insurance and Financial Services, and Yozma Group.


Nano X Imaging Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Jul-20Series BCloud Network Technology; Industrial Alliance Insurance and Financial Services; Yozma Group$59M$600MNanox Imaging is an Israeli medical imaging startup founded in 2018 by former Sony engineers focused on nanotechnology. The company developed the Nanox.ARC, a digital X-ray device weighing approximately 70 kg and costing around $10,000 to produce, compared to traditional CT scanners weighing 2,000 kg and costing $1 million to $3 million. The company offers imaging services through a pay-per-scan business model, targeting $30 per scan in markets where traditional scans average $3,000 in the US and $300 globally. In July 2020, Nanox closed a $59 million funding round that brought its Series B total to $110 million, closing out that round. The round included investors such as SK Telecom, Foxconn, Industrial Alliance, Yozma Korea, and Fujifilm. The company was valued at approximately $600 million in June 2020, shortly before this funding announcement. Nanox had secured pre-sales agreements in 13 countries representing over $300 million in projected service fees over the next three years, though the company had not yet obtained regulatory approval for its imaging machines in any market as of mid-2020. Following this funding round, the company went public on the Nasdaq in August 2020, raising $165.2 million in its IPO at $18 per share, which valued the company at approximately $1 billion.
Jun-20Series B-$25M$600MNanox Imaging is an Israeli medical imaging startup founded by former Sony engineers that develops digital X-ray systems comprising an in-hospital imaging device and companion app for early detection of medical conditions. The company's Nanox.ARC system uses MEMS-based X-ray source technology to reduce radiation exposure and costs compared to traditional imaging equipment, with plans to deploy across multiple imaging modalities including CT, fluoroscopy, and mammography. In 2020, Nanox completed multiple funding rounds: a $26 million Series A round led by Foxconn (completed by Q1 2020), a $20 million investment from SK Telecom in June 2020, and a final Series B tranche of $59 million in July 2020 that closed out the round at $110 million total. By June 2020, the company had a post-money valuation of $600 million. The company signed deployment agreements in 13 countries and announced a major partnership with SK Telecom to deploy 2,500 X-ray systems in South Korea and Vietnam, with manufacturing planned at Nanox's Korean subsidiary. In August 2020, less than a month after the Series B close, Nanox went public on the Nasdaq under ticker NNOX, raising $165.2 million at an $18 per-share price that valued the company at approximately $1 billion at IPO. The company's revenue model at that time was primarily based on licensing deals with manufacturers like Foxconn, SK, and Fujifilm, with plans to transition to a pay-per-scan service business model as regulatory clearances were obtained across markets.
Jan-20Series BFoxconn; FUJIFILM$26M-Nanox is an Israeli medical imaging startup developing a low-cost digital X-ray system called the Nanox.ARC and accompanying cloud-based software platform (Nanox.CLOUD). Founded in 2011, the company uses proprietary digital X-ray technology to create compact imaging machines with a smaller footprint and cost than traditional systems, designed to increase early disease detection in resource-constrained regions. The company operates on a pay-per-scan business model, licensing technology to major manufacturers including Foxconn and Fujifilm while building its own deployment infrastructure. In early 2020, Nanox announced a Series B funding round that was later expanded to $51 million total (combining multiple tranches announced from November 2019 onward), with participants including Foxconn, Fujifilm, SK Telecom, Industrial Alliance, and Yozma Korea. The company had signed deployment agreements in 13 countries across five continents by the time of these announcements. In June 2020, the company was valued at $600 million, and subsequently completed its IPO on August 21, 2020 at $18 per share, raising $165.21 million and achieving approximately $1 billion post-money valuation. However, the company had not reported any historical revenue data as of its IPO filing and posted significant net losses during 2020.
Jul-14Seed-$4M--

Acquisitions by Nano X Imaging

Nano X Imaging has acquired 3 companies to date.

Last acquisition by Nano X Imaging was on November 19th 2025. Nano X Imaging acquired VasoHealthcareIT for $800K (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Nano X Imaging

VasoHealthcareIT
USARAD
Zebra Medical Vision
Description
VasoHealthcareIT is a Princeton-based supplier of radiology information systems, picture archiving and communication systems, speech recognition dictation tools, and cloud storage with cybersecurity monitoring for hospitals and imaging centers. Its solutions integrate RIS/PACS platforms with HL7-compliant workflows to streamline patient data management, image distribution, and remote access. The company supports multi-site deployments and partners with major EMR vendors for interoperability in diagnostic imaging environments.
USARAD is a Miami-headquartered teleradiology company delivering subspecialty reads to hospitals in 50 U.S. states and 15 countries. Over 300 board-certified radiologists cover night shifts, weekends, and routine cases via its RadExpress platform. Founded in 2008, USARAD serves 500 facilities with turnaround under 30 minutes.
Zebra Medical Vision is an imaging analytics platform deployed in hospitals from Australia to Latin America, Europe, India, and the US. The company offers AI tools for early disease detection, holds multiple FDA clearances, and received backing from investors including Khosla Ventures, Nvidia, and Johnson & Johnson.
HQ CountryUnited StatesUnited StatesIsrael
HQ City
Nashville, TN
Fort Lauderdale, FL
Shefayim
Deal Date19 Nov 202510 Aug 202110 Aug 2021
Valuation$800K$30M$200M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Nano X Imaging acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Nano X Imaging

When was Nano X Imaging founded?Nano X Imaging was founded in 2018.
Where is Nano X Imaging headquartered?Nano X Imaging is headquartered in United States.
How many employees does Nano X Imaging have?As of today, Nano X Imaging has over 165 employees.
Who is the CEO of Nano X Imaging?Nano X Imaging's CEO is Erez Meltzer.
Is Nano X Imaging publicly listed?Yes, Nano X Imaging is a public company listed on Nasdaq.
What is the stock symbol of Nano X Imaging?Nano X Imaging trades under NNOX ticker.
When did Nano X Imaging go public?Nano X Imaging went public in 2020.
Who are competitors of Nano X Imaging?Nano X Imaging main competitors include Airdoc, Fonet, Bioneer, Findex, Kanamic Network, Fonar, Hyperfine, Infinitt Healthcare, Exagen, Apiam Animal Health.
What is the current market cap of Nano X Imaging?Nano X Imaging's current market cap is $134M.
What is the current revenue of Nano X Imaging?Nano X Imaging's last 12 months revenue is $21M.
What is the current revenue growth of Nano X Imaging?Nano X Imaging revenue growth (NTM/LTM) is 107%.
What is the current EV/Revenue multiple of Nano X Imaging?Current revenue multiple of Nano X Imaging is 4.0x.
Is Nano X Imaging profitable?No, Nano X Imaging is not profitable.
What is the current net income of Nano X Imaging?Nano X Imaging's last 12 months net income is ($63M).
How many companies Nano X Imaging has acquired to date?As of June 2026, Nano X Imaging has acquired 3 companies.
What was the largest acquisition by Nano X Imaging?$200M acquisition of Zebra Medical Vision on 10th August 2021 was the largest M&A Nano X Imaging has done to date.
What companies Nano X Imaging acquired?Nano X Imaging acquired Zebra Medical Vision, USARAD, and VasoHealthcareIT.
In how many companies Nano X Imaging has invested to date?Nano X Imaging hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Nano X Imaging

Lists including Nano X Imaging

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial